LP220253-1
riTUXimab
Active
Description
Rituximab (trade names Rituxan, MabThera and Zytux) is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is thus used to treat diseases that are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemia, transplant rejection and autoimmune disorders. Rituximab is also used with methotrexate to treat moderate-to-severe forms of rheumatoid arthritis to decrease joint pain and swelling. It is usually used for arthritis only after other medications have not worked. It is also used to treat certain types of blood vessel disease (such as Wegener's granulomatosis, microscopic polyangiitis). Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- riTUXimab
- Part Display Name
- riTUXimab
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- riTUXimab
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 利妥昔单抗 Synonyms: 重组利妥昔单抗; |
| es-ES | Spanish (Spain) | Rituximab |
| it-IT | Italian (Italy) | Rituximab |
| nl-NL | Dutch (Netherlands) | rituximab |
| fr-FR | French (France) | Rituximab |
| el-GR | Greek (Greece) | Ριτουξιμάμπη Synonyms: Ριτουξιμάμπη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://